M. J. McQueen, S. Hawken, X. Wang, S. Ounpuu, A. Sniderman, J. Probstfield, K. Steyn, J. E. Sanderson, M. Hasani, E. Volkova, K. Kazmi and S. Yusuf, “Lipids, Lipoproteins and Apolipoproteins as Risk Markers of Myocardial Infarction in 52 Countries (the INTERHEART study): A Case-Control Study,” Lancet, Vol. 372, No. 9634, 2008, pp. 224-233.

has been cited by the following article:

• TITLE: Myocardial Infarction and Intracerebral Hemorrhage in a Chinese Population: Relationship with Lipoproteins and Adipokines

  AUTHORS: Jessica Smith, Zhenjun Liu, Huiling Lu, Daowen Wang, Katherine Cianflone

  KEYWORDS: Myocardial Infarction, Intracerebral Hemorrhage, Acylation Stimulating Protein, Complement C3, Adiponectin

  JOURNAL NAME: Chinese Medicine, Vol.1 No.3, December 30, 2010

  ABSTRACT: BACKGROUND: Adipokines and inflammatory factors play an important role in disease progression. Two cardiovascular diseases which have important contributions to mortality and morbidity in China are in-tracerebral hemorrhage (ICH) and myocardial infarction (MI). Acylation stimulating protein has been shown in North American populations to have strong associations with risk factors for MI. Complement C3 (C3) a component of the innate complement immune system is the precursor protein to ASP; C3 has been impli-cated in the pathogenesis of ICH. OBJECTIVE: In this case-control study we examined the association be-tween BMI, lipoproteins adiponectin, C3 and ASP) in a Chinese population. METHODS AND RESULTS: Three groups of subjects were studied: ICH group (N = 41), MI group (N = 60) and a control group (N = 44). There was no difference in BMI for either ICH or MI compared to controls (Control: 22.3 ± 0.3 kg/m2; ICH: 21.3 ± 0.4 vs MI: 22.5 ± 0.2, ICH and MI versus control pNS). The ICH group had lower LDL-C (Control: 3.21 ± 0.13 mmol/L; ICH: 2.54 ± 0.13; MI: 2.99 ± 0.13; ICH vs control p